Corporate Member Council Representatives:
Bev Parson and Matthew Kurth
Duramed Pharmaceuticals, Inc. is the U.S. proprietary (branded) pharmaceutical subsidiary of Barr Pharmaceuticals, Inc., a global specialty pharmaceutical company that operates in more than 30 countries. The Barr Group of companies is engaged in the development, manufacture and marketing of generic and proprietary pharmaceuticals, biopharmaceuticals and active pharmaceutical ingredients. Duramed Pharmaceuticals, an innovator in women’s healthcare pharmaceutical products, focuses on providing patients with an array of women’s healthcare products, with particular emphasis on developing and marketing products that serve the reproductive and menopausal needs of women. Additional products in the U.S. proprietary company’s portfolio include hormone therapy and the more effective management of cholesterol levels in women.